Evidence map›Paper›PMID 35359937›Full record

ReviewFrontiers in immunology2022

IgG4-Related Disease With Gastrointestinal Involvement: Case Reports and Literature Review.

Xinhe Zhang, Xing Jin, Lin Guan, Xuyong Lin, Xuedan Li, Yiling Li

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. [A case of duodenal ulcer as prominent manifestation of IgG4-related disease].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xinhe ZhangGastroenterology Department, The First Affiliated Hospital of China Medical University, Shenyang, China.
Xing JinGastroenterology Department, The First Affiliated Hospital of China Medical University, Shenyang, China.
Lin GuanGastroenterology Department, The First Affiliated Hospital of China Medical University, Shenyang, China.
Xuyong LinDepartment of Pathology, The First Affiliated Hospital of China Medical University, Shenyang, China.
Xuedan LiRadiology Department, The First Affiliated Hospital of China Medical University, Shenyang, China.
Yiling LiGastroenterology Department, The First Affiliated Hospital of China Medical University, Shenyang, China.
China Medical University · CNFirst Hospital of China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IgG4-related disease is an immune-mediated chronic, systemic, and autoinflammatory disease that can affect various organs throughout the body. The most commonly affected areas are the pancreas and biliary system. Due to the diverse clinical manifestations of the disease, it affects widely distributed organs. Thus, it is often easy to misdiagnose or miss. The digestive tract is a rarely affected system, and most IgG4-related gastric diseases manifest as tumors detected by endoscopy. This article reports two special cases with IgG4-related disease involving atrophic gastritis and intestinal polyps to provide a more empirical and theoretical basis for clinical diagnosis and treatment.

Indexed as

Cholangitis, SclerosingGastritis, AtrophicImmunoglobulin G4-Related DiseaseHumansImmunoglobulin GImmunoglobulin Gatrophic gastritisautoimmune diseasesIgG4-related diseaseIgG4-related gastric diseaseIgG4-related sclerosing cholangitis

Identifiers

PMID35359937
PMCPMC8960130
OpenAlexW4220749477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.